Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,553) with videos related to
Page
of 156
Sort By:
Eclinicalmedicine
|
June 16, 2025
Efficacy and safety of HBM4003 combined with toripalimab in refractory neuroendocrine neoplasms: a multicenter, phase II study
Panpan Zhang, Kai Chen, Jianwei Yang, et al.
Frontiers in Oncology
|
February 5, 2026
Research status and prospects of molecular pathological mechanisms and novel therapeutic targets of osteosarcoma: a systematic review
Huan Jin, Cai Huang, Ying Dong, et al.
World Journal of Gastroenterology
|
June 29, 2006
Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy
Lian Zhang, Lin Shen, Jun-Ling Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2018
Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance
Yilin Li, Xiaotian Zhang, Dan Liu, et al.
Journal of Clinical Gastroenterology
|
October 29, 2020
High Prevalence of Gastrointestinal Manifestations of COVID-19 Infection in Hospitalized Patients With Cancer
Shilpa Grover, Walker D Redd, Joyce C Zhou, et al.
Journal of Cancer Research and Clinical Oncology
|
February 15, 2022
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Yanshuo Cao, Ming Lu, Yu Sun, et al.
Journal of Nanobiotechnology
|
April 3, 2022
Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization
Minjiang Chen, Jie Li, Gaofeng Shu, et al.
The Lancet. Oncology
|
September 16, 2018
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
Josep Tabernero, Paulo M Hoff, Lin Shen, et al.
Cancer Communications (London, England)
|
June 26, 2019
Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial
Tianshu Liu, Yanru Qin, Jin Li, et al.
International Journal of Cancer
|
March 22, 2023
China special issue on gastrointestinal tumors-NTRK fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment
Changsong Qi, Ting Zhou, Yuezong Bai, et al.
Page
of 156
Search research articles
Search
Showing results (1041-1050 of 1,553) with videos related to
Sort By:
Page
of 156
Eclinicalmedicine
|
June 16, 2025
Efficacy and safety of HBM4003 combined with toripalimab in refractory neuroendocrine neoplasms: a multicenter, phase II study
Panpan Zhang, Kai Chen, Jianwei Yang, et al.
Frontiers in Oncology
|
February 5, 2026
Research status and prospects of molecular pathological mechanisms and novel therapeutic targets of osteosarcoma: a systematic review
Huan Jin, Cai Huang, Ying Dong, et al.
World Journal of Gastroenterology
|
June 29, 2006
Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy
Lian Zhang, Lin Shen, Jun-Ling Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2018
Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance
Yilin Li, Xiaotian Zhang, Dan Liu, et al.
Journal of Clinical Gastroenterology
|
October 29, 2020
High Prevalence of Gastrointestinal Manifestations of COVID-19 Infection in Hospitalized Patients With Cancer
Shilpa Grover, Walker D Redd, Joyce C Zhou, et al.
Journal of Cancer Research and Clinical Oncology
|
February 15, 2022
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Yanshuo Cao, Ming Lu, Yu Sun, et al.
Journal of Nanobiotechnology
|
April 3, 2022
Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization
Minjiang Chen, Jie Li, Gaofeng Shu, et al.
The Lancet. Oncology
|
September 16, 2018
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
Josep Tabernero, Paulo M Hoff, Lin Shen, et al.
Cancer Communications (London, England)
|
June 26, 2019
Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial
Tianshu Liu, Yanru Qin, Jin Li, et al.
International Journal of Cancer
|
March 22, 2023
China special issue on gastrointestinal tumors-NTRK fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment
Changsong Qi, Ting Zhou, Yuezong Bai, et al.
Page
of 156